KEYMAKER-U03 Substudy 03B: Pembrolizumab (pembro) and targeted therapy combinations for advanced clear cell renal cell carcinoma (ccRCC) Meeting Abstract
| Authors: | Albiges, L.; Suárez, C.; Powles, T.; Motzer, R. J.; Stadler, W. M.; Miller, W. H. Jr; Rojas, C.; Peer, A.; Goh, J. C.; Park, S. H.; Waddell, T.; Barthelemy, P.; Gajate, P.; Weickhardt, A.; Faust, G.; Perini, R. F.; Bousserouel, L.; Wang, D.; Hammers, H. J.; Beckermann, K. |
| Abstract Title: | KEYMAKER-U03 Substudy 03B: Pembrolizumab (pembro) and targeted therapy combinations for advanced clear cell renal cell carcinoma (ccRCC) |
| Meeting Title: | 2025 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2025 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-10 |
| Language: | English |
| ACCESSION: | WOS:001454809900003 |
| DOI: | 10.1200/JCO.2025.43.5_suppl.440 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 440 -- Source: Wos |
